ViaNautis Bio
25 Nov, 2024
Dr Fran Crawford. Courtesy – Howard Group.
ViaNautis recently signed a multi-year strategic collaboration agreement with Eli Lilly and Company and earlier this year took a 10-year lease on 10,825 sq ft of lab, write-up and office space at Howard Group’s Unity Campus in Sawston.
Formerly known as SomaServe, ViaNautis is at the forefront of advancing revolutionary therapies for Central Nervous System rare diseases and cystic fibrosis. It raised $25m Series A funding in 2023.
ViaNautis was spun out of UCL in 2018 by co-founders Dr Francesca Crawford, Dr Denis Cecchin, and Professor Giuseppe Battaglia, inventor of polyNaut® and honorary professor at UCL.